These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33706995)

  • 1. [Cancer and cardiovascular risk].
    Blanch Gracia P; Mena Sebastià E; Villanueva Vázquez R; Tirapu Sola L; Losa Gaspà F; Freixa-Pamias R; Armario P
    Hipertens Riesgo Vasc; 2021; 38(3):e1-e9. PubMed ID: 33706995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevention of cardiovascular disease in cancer survivors.
    Daher IN; Daigle TR; Bhatia N; Durand JB
    Tex Heart Inst J; 2012; 39(2):190-8. PubMed ID: 22740730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer and cardiovascular disease].
    Lahoz C; Valdivielso P; González-Alegre MT; García-Iglesias MF; Estirado E; Mostaza JM
    Clin Investig Arterioscler; 2015; 27(5):221-5. PubMed ID: 25772547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease in cancer survivors.
    Okwuosa TM; Anzevino S; Rao R
    Postgrad Med J; 2017 Feb; 93(1096):82-90. PubMed ID: 28123076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors.
    Pluimakers VG; van Waas M; Neggers SJCMM; van den Heuvel-Eibrink MM
    Crit Rev Oncol Hematol; 2019 Jan; 133():129-141. PubMed ID: 30661649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardio-oncology, the myth of Sisyphus, and cardiovascular disease in breast cancer survivors.
    Mavrogeni SI; Sfendouraki E; Markousis-Mavrogenis G; Rigopoulos A; Noutsias M; Kolovou G; Angeli C; Tousoulis D
    Heart Fail Rev; 2019 Nov; 24(6):977-987. PubMed ID: 31134427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second malignant neoplasms and cardiovascular disease following radiotherapy.
    Travis LB; Ng AK; Allan JM; Pui CH; Kennedy AR; Xu XG; Purdy JA; Applegate K; Yahalom J; Constine LS; Gilbert ES; Boice JD
    J Natl Cancer Inst; 2012 Mar; 104(5):357-70. PubMed ID: 22312134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular complications of cancers and anti-cancer therapy].
    Vyskočil J; Petráková K; Jelínek P; Furdek M
    Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician.
    Dillenburg RF; Nathan P; Mertens L
    Eur J Pediatr; 2013 Sep; 172(9):1149-60. PubMed ID: 23361962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
    Boekel NB; Schaapveld M; Gietema JA; Russell NS; Poortmans P; Theuws JC; Schinagl DA; Rietveld DH; Versteegh MI; Visser O; Rutgers EJ; Aleman BM; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1061-72. PubMed ID: 27026313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Cardiovascular Risk Factors Among Cancer Patients in the United States.
    Rubens M; Appunni S; Ramamoorthy V; Saxena A; Das S; Bhatt C; Boulanger BK; Viamonte-Ros A; Veledar E
    Metab Syndr Relat Disord; 2019 Oct; 17(8):397-405. PubMed ID: 31241405
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiotoxicity among adult survivors suffered from childhood malignancies.
    Petropoulos AC; Moschovi M
    Hell J Nucl Med; 2019; 22 Suppl 2():34-40. PubMed ID: 31802042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Risk in Survivors of Cancer.
    Zheng HC; Onderko L; Francis SA
    Curr Cardiol Rep; 2017 Jul; 19(7):64. PubMed ID: 28550591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
    van Leeuwen FE; Ng AK
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors.
    Haugnes HS; Oldenburg J; Bremnes RM
    Urol Oncol; 2015 Sep; 33(9):399-406. PubMed ID: 25554583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term arterial complications of chemotherapy in patients with cancer.
    Svilaas T; Lefrandt JD; Gietema JA; Kamphuisen PW
    Thromb Res; 2016 Apr; 140 Suppl 1():S109-18. PubMed ID: 27067963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study.
    Hamood R; Hamood H; Merhasin I; Keinan-Boker L
    J Cardiol; 2019 Apr; 73(4):280-291. PubMed ID: 30587455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
    Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
    Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impending Epidemic of Cardiovascular Diseases in Patients With Cancer in Japan.
    Okura Y; Ozaki K; Tanaka H; Takenouchi T; Sato N; Minamino T
    Circ J; 2019 Oct; 83(11):2191-2202. PubMed ID: 31534064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.